| Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma MC Kyrtsonis, TP Vassilakopoulos, N Kafasi, S Sachanas, T Tzenou, ... British journal of haematology 137 (3), 240-243, 2007 | 202 | 2007 |
| Genetics and prognostication in splenic marginal zone lymphoma: revelations from deep sequencing M Parry, MJJ Rose-Zerilli, V Ljungström, J Gibson, J Wang, R Walewska, ... Clinical Cancer Research 21 (18), 4174-4183, 2015 | 165 | 2015 |
| Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care TP Vassilakopoulos, GA Pangalis, A Katsigiannis, SG Papageorgiou, ... The oncologist 17 (2), 239-249, 2012 | 135 | 2012 |
| Rituximab monotherapy is highly effective in splenic marginal zone lymphoma C Kalpadakis, GA Pangalis, MN Dimopoulou, TP Vassilakopoulos, ... Hematological oncology 25 (3), 127-131, 2007 | 119 | 2007 |
| Treatment of splenic marginal zone lymphoma with rituximab monotherapy: progress report and comparison with splenectomy C Kalpadakis, GA Pangalis, MK Angelopoulou, S Sachanas, ... The Oncologist 18 (2), 190-197, 2013 | 100 | 2013 |
| Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity? A Xochelli, C Kalpadakis, A Gardiner, P Baliakas, TP Vassilakopoulos, ... Blood, The Journal of the American Society of Hematology 123 (8), 1199-1206, 2014 | 95 | 2014 |
| Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue of the salivary glands: a multicenter, international experience of 248 patients (IELSG 41) AE Jackson, M Mian, C Kalpadakis, GA Pangalis, A Stathis, E Porro, ... The Oncologist 20 (10), 1149-1153, 2015 | 69 | 2015 |
| PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent … TP Vassilakopoulos, GA Pangalis, S Chatziioannou, S Papageorgiou, ... Leukemia 30 (1), 238-242, 2016 | 52 | 2016 |
| Effect of the nonpeptide thrombopoietin receptor agonist eltrombopag on megakaryopoiesis of patients with lower risk myelodysplastic syndrome I Mavroudi, K Pyrovolaki, K Pavlaki, A Kozana, M Psyllaki, C Kalpadakis, ... Leukemia Research 35 (3), 323-328, 2011 | 52 | 2011 |
| Treatment of splenic marginal zone lymphoma: should splenectomy be abandoned? C Kalpadakis, GA Pangalis, TP Vassilakopoulos, S Sachanas, ... Leukemia & Lymphoma 55 (7), 1463-1470, 2014 | 51 | 2014 |
| Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance C Kalpadakis, GA Pangalis, S Sachanas, P Tsirkinidis, FN Kontopidou, ... Blood, The Journal of the American Society of Hematology 132 (6), 666-670, 2018 | 49 | 2018 |
| Favorable outcome of primary cutaneous marginal zone lymphoma treated with intralesional rituximab MC Kyrtsonis, MP Siakantaris, C Kalpadakis, MN Dimopoulou, ... European journal of haematology 77 (4), 300-303, 2006 | 48 | 2006 |
| Combination of rituximab with chlorambucil as first line treatment in patients with mantle cell lymphoma: a highly effective regimen S Sachanas, GA Pangalis, TP Vassilakopoulos, P Korkolopoulou, ... Leukemia & lymphoma 52 (3), 387-393, 2011 | 47 | 2011 |
| Differential diagnosis of Waldenström's macroglobulinemia and other B-Cell disorders GA Pangalis, MC Kyrtsonis, FN Kontopidou, MP Siakantaris, ... Clinical lymphoma 5 (4), 235-240, 2005 | 44 | 2005 |
| Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group E Katodritou, E Terpos, S Delimpasi, M Kotsopoulou, E Michalis, ... Blood cancer journal 8 (3), 31, 2018 | 43 | 2018 |
| Isolated central nervous system relapses in primary mediastinal large B‐cell lymphoma after CHOP‐like chemotherapy with or without Rituximab SG Papageorgiou, P Diamantopoulos, G Levidou, MK Angelopoulou, ... Hematological Oncology 31 (1), 10-17, 2013 | 41 | 2013 |
| Study of the quantitative, functional, cytogenetic, and immunoregulatory properties of bone marrow mesenchymal stem cells in patients with B-cell chronic lymphocytic leukemia C Pontikoglou, MC Kastrinaki, M Klaus, C Kalpadakis, P Katonis, ... Stem cells and development 22 (9), 1329-1341, 2013 | 40 | 2013 |
| Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory/resistant multiple myeloma patients treated with bortezomib K Anargyrou, E Terpos, TP Vassilakopoulos, A Pouli, S Sachanas, ... haematologica 93 (3), 451-454, 2008 | 39 | 2008 |
| Serum levels of soluble syndecan-1 in Hodgkin's lymphoma TP Vassilakopoulos, MC Kyrtsonis, A Papadogiannis, G Nadali, ... Anticancer research 25 (6C), 4743-4746, 2005 | 38 | 2005 |
| Non-gastric extra-nodal marginal zone lymphomas–a single centre experience on 76 patients C Kalpadakis, GA Pangalis, TP Vassilakopoulos, MC Kyrtsonis, ... Leukemia & lymphoma 49 (12), 2308-2315, 2008 | 37 | 2008 |
